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The Influenza virus M2 ion channel has good potential as a target for antiviral 
drugs, as the channel is necessary for viral replication. M2 of Influenza A and B viruses 
has beenstudied extensively, and is understood to function as a proton channel. Antiviral 
drugs like amantadine and rimantadine have been used to block the function of Influenza 
A virus M2. Influenza C virus M2 has also been researched and is understood to act as a 
chloride ion channel. However, the M2 channel of Influenza D virus (DM2) has been 
studied very little, and the activity and mechanism of the channel are unknown. To test 
the function of the channel, the protein was expressed in a Xenopus laevis oocyte system, 
and expression was confirmed with immunofluorescence and mass spectrometry. DM2 
expressed in oocytes was analyzed using a two-electrode voltage clamp. The native DM2 
protein was tested along with C-terminal altered M2 and M2 altered at an intracellular 
motif. The native DM2 channel was found to exhibit ion channel activity and chloride 
specificity comparable to that of Influenza C virus M2, and C-terminal and 
transmembrane altered M2 was found to exhibit altered ion channel activity from native 
DM2. These results suggest that DM2 functions as a chloride ion channel. 
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Figure 1: Swine as a mixing vessel for Influenza. Influenza virus has species-specificity based on the 
linkages of sialic acid moieties on receptors of hosts. Human Influenza virus recognizes the sialic acid with 
linkage α(2,6), avian Influenza virus recognizes the sialic acids with linkage α(2,3), and swine Influenza 
virus recognizes both [11]. As swine cells have each sialic acid linkage recognized by avian and human 
Influenza viruses, human and avian Influenza viruses have the capacity to infect a swine host [9]. This 
creates an environment in swine where the different Influenza virus species can infect the same cells and 
potentially engage in genetic reassortment, causing new Influenza types to emerge....................................17 
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rupture of the virus particle and the endosomal membrane (3). The viral ribonucleoproteins are transported 
to the cell nucleus (4), and viral mRNA is synthesized (5). The viral mRNAs encoded genes are then 
translated into proteins (6). Viral proteins are transported to the cell membrane with newly synthesized 
viral ribonucleoproteins (7). New Influenza viruses are budded out of the cell (8). M2 is a critical part of at 
least two of these stages. The first is the release of vRNPs into the host cell cytoplasm (3). M2 is 
responsible for channeling ions and acidifying the virus interior, causing the fused endosome to rupture. 
The second stage is the budding of new viruses from the host cell (7 and 8). M2, along with HA and 
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Figure 3: Chemical structure of amantadine. Amantadine (PubChem CID, 2130) is an antiviral drug that 
inhibits Influenza virus reproduction by blocking the M2 ion channel [16,17]. Amantadine is no longer 
recommended as an antiviral treatment in the first choice, as the drug is only semi-effective against recent 
virus types. The drug has been tested against Influenza C, with no evidence for the inhibition of M2 [31].19 
Figure 4. Amino acid sequences. A. Primary structures of Influenza C virus M2 protein (CM2; 
Sequence ID, YP_089658.1 (C/Ann Arbor/1/1950)) and Influenza D virus M2 protein (DM2; AFJ19025 
(D/Swine/Oklahoma/1334/2011)). CM2 contains a 24 amino-acid-signal sequence (−24 to −1). Mature 
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oligomerization sites (‘*’; Cys1, Cys6, Cys20), a glycosylation site (Asn11, ‘g’) and a palmitoylation site 
(Cys65, ‘p’). In DM2, the predicted transmembrane domain was indicated by underline. The YxxxK motif, 
Tyr72 and Lys76 in D, was indicated by the bold face. A C-terminal variant in Dm has a spacer GAG and a 
cMyc-tag EQKLISEEDL. A  C-terminal variant in DM2, DM2a, has an extra peptide from the vector, 
pNCB1. B. Structures of M2 proteins. AM2. M2 protein from Influenza A virus (AAA43303 
(A/Udorn/1972(H3N2)) has a NMR structure (residues 22–62; PDB ID, 2L0J) and crystallographic 
structure (21–46; 4QKL). BM2. M2 protein from Influenza B virus (ACF54325.1 (B/Taiwan/70061/2006)) 
has a NMR structure (1–33; 2KIX). CM2. M2 protein from Influenza C virus has structures by site-specific 
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Figure 5. 3D-structure of M2 protein. A. The structure of AM2 was solved experimentally by nuclear 
magnetic resonance spectroscopy (NMR; structures were deposited in Protein Data Bank with the ID cede 
2L0J; the NMR structure contains multiple structures and shown is model 1 out of 8 is shown). The AM2 
adopts a homo-tetramer configuration, and the middle of the assembly contains a pre. The valve residues, 
His37 and Trp41, face inward within the pore on each monomer. B. The monomer structure of AM2 with 
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valve resides, which control ion flow by pseudo-cation-pi interaction. C. A theoretical model of DM2 in 
monomer format.............................................................................................................................................21 
Figure 6: pNCB1 plasmid vector. 1. Plasmid construction. DM2, DM2cMyc, and CM2 were each cloned 
into the pNCB1 vector with the BamHI and XbaI sites. DM2a was cloned into pNCB1 using SmaI and XbaI. 
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and their structural genes are 459, 495, 504, and 417 bp, respectively. The HindIII linearization locations 
and lengths for synthesized cRNA for each respective plasmid construct are also shown. 2. The sequence of 
the T7 promoter. The +1 of cRNA synthesis was shown. 3. Restriction sites. The multiple cloning sites 
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INTRODUCTION: Literature Review and Aim 
1.1 Influenza virus 
Influenza virus can infect multiple species of animals, including humans [1, 2], and 
can cause fever, sneezing, and more serious diseases like pneumonia. While most 
influenza virus infections have mild symptoms, genetic shift, drift, and reassortment 
events have resulted in highly pathogenic strains [3]. To date, four influenza virus species 
have been identified, namely A, B, C, and D [2, 4]. Influenza A infects several different 
species including humans, as well as porcine, bovine, and canine species [5]. Types B 
and C infect humans and pigs [6]. Type D is a relatively newly identified type of 
influenza virus, which has been found to infect cattle and pigs [4]; it was recognized as a 
new virus type by the International Committee of Taxonomy in 2016 (talk.ictvonline.org).  
Influenza D virus infection in cattle is typically asymptomatic [7, 8]. However, its 
infection in swine can result in clinical disease. Swine can also be infected with all other 
types of influenza viruses (type A-C). As a result, swine can serve as a “mixing vessel” 
for highly pathogenic influenza viruses, including those with zoonotic potential into the 
human population [9] (Figure 1). A recent study has confirmed that people working in 
close proximity to calves have higher rates of seropositivity to the influenza virus (94%), 
more so than the general population (1.3%)  [10]. Because of the potential for crossover 
to a human host, it is important to understand the functions of the Influenza D proteome. 
 
 
 
2 
1.2 Influenza Virus Life Cycle 
Influenza virus begins its life cycle by entering a host cell (Figure 2). The surface 
of the virus has hemagglutinin (HA), neuramidase (NA), and matrix protein 2 (M2) [13]. 
HA binds to sialic acid moieties from the receptors on the host cell membrane. Species 
specificity of Influenza virus infection is determined by the linkages between sialic acids 
and the carbohydrates shared within their glycoproteins; these linkages are recognized by 
HA. Human Influenza viruses recognize sialic acids with α(2,6) linkages, avian Influenza 
virus recognizes sialic acids with α(2,3) linkages, and swine Influenza virus recognizes 
both types of sialic acids [11]. Binding of HA to the sialic acid receptor triggers receptor-
mediated endocytosis, which allows the Influenza virus to enter the cell as an endosome. 
The acidity of the inside of endosome (pH 5-6) induces fusion between HA and the 
endosomal membrane; and also then activates the M2 protein. The M2 protein acts as an 
ion channel to conduct protons and acidify the interior of the viral particle, rupturing it 
with the endosome and releasing the viral ribonucleoproteins (vRNP) into the cytoplasm 
[12]. The vRNPs are transported to the host cell nucleus and express their own encoding 
genes. The produced Influenza proteins are transported to the cell membrane, and bud out 
of the cell.  
 
1.3 Influenza Virus M2 Protein 
M2 is necessary in at least two stages of Influenza virus reproduction (Figure 2). 
The first stage is the release of vRNPs into the host cell cytoplasm. M2 is responsible for 
acidifying the virus interior, causing the virus to rupture the endosomal membrane. The 
second stage is the budding of new viruses from the host cell. It is not yet clear what 
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mechanism is used by M2, but it has been demonstrated that virus budding is attenuated 
when the M2 C-terminal domain is mutated [37]. 
 
1.4 Molecular Basis of Influenza M2 Ion Channel 
The influenza A virus M2 protein (AM2) is involved in the release of viral RNPs 
from the endosome (uncoating) and the transport of hemagglutinin to the cell surface via 
the trans-Golgi network [19-21]. In both processes, acidification of the external 
environment around the virus activates the M2 proton channel capability, thus leading to 
virus rupture. 
The AM2 protein consists of an N-terminal (external) domain, a transmembrane 
domain, and a C-terminal (internal) domain (Figure 4 and 5). The C-terminal domain is 
amphipathic, and it has been found to be important for tetramer formation [22,23] and ion 
conductance [24]. The tandem transmembrane helices of the AM2 monomers turn left at 
23 form vertical of the bundle, and there is an inner pore at the center of the tetramer [22]. 
Methyl groups at Val27 (Figure 5B) keep the opening pore with the diameter of 3.1 Å. 
The conformation of the channel holds water molecules in the inner pore, which 
contributes the flow of protons. The pore of the channel is widest at Gly34 with the 
diameter at 6 Å. The C-terminal region narrows down to 1.7 and 1.4 Å at residues His37 
and Trp41, respectively. The Trp41 residues are within van der Waals distance of each 
other, and are thought to bind in hydrogen bonding to keep the gate closed. 
The crystal structure of AM2 has been solved at high-resolution (PDB ID, 4QKL, 
deposited in the monomer format) [25]. Based on this model, electrophysiological 
behaviors of the pH-gated M2 proton channel were explained by the simulations [26]. 
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Specifically, Val27 and Ser31 in the amino–terminal and His37 and Trp41 of carboxyl-
terminal were shown to act as a hinge and a gate, respectively (HxxxW motif hereafter) 
[27]. NMR structures of the channel domain of M2 (2L0J; deposited in a tetramer format; 
Figure 5) [28] were also reported, which were consistent with the structure obtained by 
the X-ray crystallography. 
The Influenza B virus M2 protein (BM2) also contains the HxxxW motif [27], 
and the protein structure was solved by NMR (2KIX; deposited in a tetramer format) [29]. 
The Influenza C M2 protein (CM2) was reported by Hongo et al. [30] 
((C/Yamagata/1/1988); Figure 4), and it was identified as a voltage chloride ion channel 
[31]. While CM2 does not contain the HxxxW motif, the helical region contains a YxxxK 
motif found through visual observation (Figure 4). CM2 undergoes a proteolytic 
intracellular naturalization process that removes the leading 24 amino acids [32]. Mature 
CM2 consists of an amino-terminal extracellular domain, transmembrane domains, and a 
carboxyl-terminal internal domain [32, 33]. In a different isolate, (C/Ann Arbor/1/1950) 
[34], a transmembrane domain, (Tyr27-Val46) was predicted by site-specific infrared 
dichroism analyses and a global molecular dynamics search [18]. Side chains of Leu31, 
Leu34, Met41, and Leu44 residues were predicted to point to the center of the tetramer 
assembly. CM2 undergoes oligomerization by disulfide bonding among Cys1-Cys6-
Cys20 [35]. CM2 undergoes glycosylation at Asn11 [32, 33] and palmitoylation at Cys65 
[36]. Three amino acid substitutions between Yamagata and Ann Arbor isolates were 
found to be located outside of the transmembrane domain. 
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1.5 Biomedical significance 
Influenza infection is typically prevented by administering an efficacious vaccine 
[14, 15].  However, if infection has already occurred, the only treatment option is the use 
of antivirals. Unfortunately, owing to the inherent instability and high mutation rate of 
influenza genomes, most current antivirals are no longer effective at inhibiting influenza 
virus replication. The only currently available anti-viral that targets the Influenza M2 
protein ion channel (M2; Figure 4) [16, 17] is called amantadine (PubChem CID, 2130) 
(Figure 3), and is only partially effective. Thus, there is an urgent need to develop an M2 
ion channel blocker capable of suppressing viral infection. 
 
1.6 Aims 
The type D proteome (D/Swine/Oklahoma/1334/2011), including the M2 protein, 
shares more sequence similarity with the type C proteome than with the type A or B 
proteomes [10]. As such, many of my inferences about the structure and function of the 
DM2 protein are derived from what we know about CM2. I hypothesized that DM2 has 
voltage-gated chloride ion channel activity similar to that of CM2, and that this channel 
might depend on the YxxxK motif present in both channels (Figure 4, 5c). To test the 
hypothesis, I chose to use the two-electrode voltage-clamp technique (TEVC) technique 
coupled with a heterologous expression system with Xenopus oocytes because this 
system is well-established. 
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Chapter II MATERIALS AND METHODS 
2.1 Plasmid Construction 
A Xenopus oocyte expression vector, pNCB1 (GenBank Accession number MF984401), 
was constructed with pGEMHE used as a base [38], which contains a T7 promoter, 
Xenopus laevis -globin 5’-UTR, multiple cloning sites, Xenopus laevis  -globin 3’-
UTR, poly-A sequences. Native CM2 (Locus, YP_089658.1 (C/Ann Arbor/1/50)), and 
native and modified DM2 (Locus, AFJ19025 ((D/Swine/Oklahoma/1334/2011)) (Figure 
4) were synthesized and cloned into pNCB1 (Figure 6). DNA was synthesized and cloned 
by GenScript (Figure 14; Piscataway, New Jersey, USA).  
 
2.2 cRNA Synthesis  
Before cRNA preparation, pNCB1 constructs containing DM2 structural genes were 
linearized by HindIII using a 20 µl reaction volume: 2 μ  FastDigest buffer 
(ThermoFisher, Waltham, Massachusetts), 1 μ  HindIII enzyme, 1 µg plasmid D A, and 
filled to 20 µL with H2O. DNA was recovered by ethanol precipitation using 1 µL of 0.5 
M EDTA, 2 µL of 4M ammonium acetate, and 46 µL of 100% ethanol, for a total 
precipitation volume of 69 µL. The mixture was kept at -20˚C for at least 20 minutes. 
Precipitated DNA was recovered by centrifugation at 21,000 reciprocal centrifugal force 
(RCF) for 15 minutes at 4 C. After removal of supernatant, the precipitate was dried in air. 
DNA was dissolved in 10 µL of 10 mM Tris-HCl pH 8.0 1 mM EDTA (TE) buffer. 
Linearized DNA was stored at -20˚C. Linearized DNA was analyzed using 1% agarose 
gel electrophoresis (Figure 7). To estimate the concentration of recovered DNA, I used 
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ImageJ software [39]. The 1 kb GeneRuler DNA ladder (Thermo Fisher) in the same 
agarose gel was used to obtain the concentration reference.  
Invitrogen Ambion mMESSAGE mMACHINE T7 Transcription Kit (Thermo 
Fisher) was used in the 5’-capped mRNA (cRNA) synthesis: 10 µL 2X NTP/CAP 
solution, 2 µL 10X reaction buffer, 1 µL T7 RNA polymerase, 0.1-1 µg linearized DNA, 
and filled to 20 µL with H2O. mRNA was recovered by precipitation in 30 µL nuclease-
free water and 30 µL LiCl kept at -20 C for 30 min. The cR A was recovered by 
centrifugation at 21,000 RCF for 15 min. at 4  C, rinsing with 70(v/v)% ethanol, and 
centrifuging again. The recovered cRNA was dissolved in phosphate buffered saline 
(PBS) consisting of 137 mM NaCl, 2.7 mM KCl, 10 mM Na2HPO4, and 1.8 mM 
KH2PO4-HCl pH 7.4. Recovered cRNA was analyzed with agarose gel electrophoresis 
(Figure 7) and quantified by the Qubit HS RNA Assay system (Thermo Fisher) (Table 1) 
(Figure 8). cRNA was stored at −20˚C up to 30 days. 
 
2.3 Injection of Xenopus Oocytes with cRNA 
Pipettes were pulled with a pipette puller P-97 (Sutter Instrument, Novato, California) to 
have tips with diameters less than 22.5 µm and lengths of about 2.5 cm. Pipette tips were 
inspected with the Microforge MF-830 (Narishige International USA, East Meadow, 
New York) to ensure the tips were smooth at the edges, as to not tear the oocyte 
membrane, and also to verify that the diameter was acceptable. Defolliculated Xenopus 
oocytes were purchased from Xenopus 1 (Dexter, Michigan). Each individual oocyte was 
placed in ND96 buffer (96 mM NaCl, 2 mM KCl, 1.8 mM CaCl2, 1 mM MgCl2, and 5 
mM HEPES-NaOH pH 8.5) [31] and injected with 50.6 nL of cRNA using Auto-
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Nanoliter Injector Nanoject II (Drummond Scientific, Broomall, Pennsylvania) (Figure 9). 
Other oocytes were injected with PBS as a control. 
 
2.4 Immunofluorescent Imaging 
I used MYC Mouse Antibody 9E 10 (Developmental Studies Hybridoma Bank, 
University of Iowa, Iowa City, Iowa) to detect the cMyc-tag at the C-terminus of the 
construct. Three oocytes injected with cRNA or PBS and left to incubate for five days 
were fixed in 4% paraformaldehyde and blocked in 5% horse serum in Tris-buffered 
saline (50 mM Tris; 150 mM NaCl, to pH 7.6 with HCl) (TBS) solution. The oocytes 
were incubated in 1:500 anti-Myc mouse antibody 9E10 diluted in 1% skim milk in TBS-
T solution (TBS containing 0.05% Tween-20), and were then incubated in 1:250 Alexa-
Fluor 488 donkey anti-mouse antibody (Thermo Fisher) diluted in 1% skim milk in TBS-
T solution. Oocytes were then observed under the Olympus FV500 Confocal Microscope 
at the Morrison Microscopy Core Research Facility (University of Nebraska-Lincoln). 
 
2.5 Mass Spectrometry of Plasma Membranes 
Five Xenopus oocytes injected by DM2cMyc cRNA or PBS were incubated for 3 days at 
18˚C. Oocytes were then placed in either 20 µ  (2 µg) trypsin in 1 0 µ   D 6 buffer or 
20 µ  trypsin in 1 0 µ  50 mM ammonium bicarbonate.  ach treatment was incubated at 
25  C for 5 h. Aliquots of 5µL were then sampled from each treatment. To remove salts, 
the sample was subjected to the nanoLC-MS/MS using a 1h gradient on a 
0.075mmx250mm C18 Waters CSH column feeding into a Q-Exactive HF mass 
spectrometer. All MS/MS samples were analyzed using Mascot (Matrix Science, London, 
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UK; version 2.5.1). Mascot was set up to search the cRAP_20150130 db (113 entries) 
uniprot-Xenopus_laevis_20170615 db (42878 entries) and a custom database containing 
our construct sequences. Mascot search was performed with a fragment ion mass 
tolerance of 0.060 Da, and a parent ion tolerance of 10.0 PPM. Deamidation of 
asparagine and glutamine, and oxidation of methionine were specified in Mascot as 
variable modifications. Scaffold (version Scaffold_4.8.1, Proteome Software Inc., 
Portland, OR) was used to validate MS/MS-based peptide and protein identifications. 
Peptide identifications were accepted if they could be established at a 1% false discovery 
rate (FDR) by the Peptide Prophet algorithm [40] with Scaffold deltamass correction. 
Protein identifications were accepted if they could be established at a 1% FDR and 
contained at least 1 identified peptide.  Protein probabilities were assigned by the Protein 
Prophet algorithm [41]. This part of work is done with the Proteomics and Metabolomics 
Core Research Facility (University of Nebraska-Lincoln). 
 
2.6 Two-Electrode Voltage Clamp 
Glass electrodes were pulled with the P-97 puller, and broken to about 5 cm. The tips 
were about 3 mm long and 22.5 µm or less in diameter. Each electrode was filled with 
filter-sterilized 3 M KCl, and placed on the voltage and current electrode holders for the 
Oocyte Clamp Amplifier OC-725C (Warner Instruments, Hamden, Connecticut). The 
OC-725C amplifier was connected to the Digidata 1550A Digitizer (Molecular Devices, 
Sunnyvale, California) (Table 2). pCLAMP software (Molecular Devices) was 
configured to perform the voltage clamp experiment (Table 3). Each oocyte was placed in 
a bath containing ND96 at pH 8.5. The bath electrodes were set and the voltage and 
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current electrodes were used to puncture the oocyte (Figure 10). pCLAMP software was 
used to control the holding potential of the oocyte and record the resulting currents. The 
holding potential was decreased from 60 mV to −200 mV incrementally by −10 mV for 
two seconds at each step. Measurements of CM2 ended at −130 mV, DM2 at −160 mV, 
and control at −200 mV, depending on the amplitude of the resulting current. Data 
analysis was performed using the Boltzmann charge-voltage approximation 
     
    
    
      
   
    
 where V is membrane potential, Imax is maximal current, Vmid is potential when current is 
half-maximal, Vc is voltage required to change current e-fold, and C is constant y-offset. 
This approximation was done automatically in the pCLAMP program (Molecular 
Devices) [45, 46], and obtained the membrane potential which gives a half of maximal 
opening of the ion channel (Vmid) as one of the representative values. 
  
CHAPTER III RESULTS AND ANALYSIS 
3.1 Detection of DM2 by Mass Spectrometry 
Tryptic mass spectrometry [42] was used to confirm the presence of the DM2cMyc 
protein in Xenopus oocytes. Trypsin was added to an aliquot of ND96 medium containing 
an oocyte injected with cRNA encoding cMyc-tagged DM2. After two hours, a fraction 
of media was taken, and was passed through a desalting C18 column, and then was 
subjected to mass spectrometry (Figure 11). The peptide sequence, 35 amino acids, 
corresponding to the junction area between the amino terminal of the DM2, the spacer, 
and a portion of cMyc-tag was identified (Figure 4 and 11). In the tryptic mass 
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spectrometry, the recovery of membrane associated protein is often limited [42]. The 
identified fragment wasn’t protected by the membrane. 
 
3.2 Heterogeneous Gene Expression of Influenza D M2 Protein Using Xenopus 
Oocyte 
A DM2 construct with a carboxyl end cMyc-tag was used to assay the expression of the 
DM2 protein in Xenopus laevis oocytes (Figure 4, S1). DM2 conjugated with the cMyc 
tag was expressed under the Xenopus -globin 5’-UTR in the pNCB1 vector, which is 
adapted from pGEMHE [38]. In vitro transcribed cRNA was injected into the oocyte, and 
the oocyte was incubated in  D 6 medium at 1 ˚C for 4  hours. The in ected oocytes 
were subjected to staining to detect the DM2 protein through the cMyc epitope-tag using 
primary 9E10 antibody and secondary Alexa-Fluor 488 antibody. The stained oocytes 
were observed through confocal microscopy (Figure 12). A distinct green band was 
observed in the oocytes injected with cRNA encoding cMyc-tagged DM2, while the 
control injected with phosphate buffer saline did not show any florescence. This result 
was consistent with the observation with CM2 by Hongo et al. [30], although there were 
experimental differences, such as that they used the rabbit immune serum against the 
GST fusion protein containing CM2 protein. Thus, the result indicated that cMyc-tagged 
DM2 was produced in Xenopus oocytes upon injection of the cRNA, and formed a layer 
near the surface of the oocyte. 
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3.3 Voltage Gate of DM2 and Mutants 
Intact Xenopus oocytes (5 total) injected by phosphate buffer saline (PBS) were subjected 
to the Two Electrode Voltage-Clamp (TEVC) method after 2 days of incubation (Figure 
13). The oocyte exhibited an inward current of about -5 A when the membrane voltage 
was kept at -200 mV. The behaviors of intact and PBS-injected oocytes were similar, and 
the injection per se did not seem to change the electrophysiological signature of the 
oocyte. The inward current was most likely the result of innate voltage-gated chloride 
channels in the Xenopus oocyte [43-46]. 
Oocytes injected by cRNA encoding DM2cMyc and by PBS were compared by 
their electrophysiological behaviors using TEVC. The DM2cMyc-expressed oocytes (5 
total) showed about -4 A of inward current at the membrane voltage of -150 mV, while 
PBS-injected oocytes showed inward current at -0.1 A (Figure 13). The charge-voltage 
Boltzmann distribution model was applied to represent the gating voltage as the midpoint 
of the sigmoid curve, Vmid (Table 4). The averaged Vmid values, <Vmid>, for DM2 cMyc-
injected oocyte and PBS-injected oocyte were -155  11 mV and -200  2mV, 
respectively. Thus, I interpreted the inward current observed in DM2cMyc RNA-injected 
oocyte was due to the voltage-gated ion channel activity of the expressed protein.  I 
concluded the same experimental procedure is applicable to other constructs, including 
DM2 without a tag. 
To test if DM2 has ion channel activity, voltage-gated current was observed in 
five oocytes injected with either RNA encoded by the M2 protein from influenza type C 
(CM2) or DM2 were subjected to the TEVC (Figure 13). The CM2 construct used in this 
study provided induced inward current -4.5 A when the membrane voltage was kept at  
 
 
13 
-130 mV, which was consistent with previously reported observations by Hongo et al. 
[30, 31]. The DM2 construct gave -3.6 A of inward induced current at the membrane 
voltage of -130 mV. The <Vmid> for CM2 and DM2 injected oocytes were -141  10 mV 
and -146  3 mV, respectively. 
The ion channel activity of a DM2 variant with an extra 16 amino acids added to 
the C-terminal tail (DM2a) (Figure 4A) was observed. The channel had an inward current 
of about -5.5 µA at a holding potential of -170 mV (Figure 13), and had a <Vmid> of -168 
 4 mV (Table 4). DM2 variants were also constructed by GenScript by substituting Y72 
and K76 with alanine. Y72A had an inward current of about -7 µA at a holding potential 
of -110 mV (Figure 13), and had a <Vmid> of -103  2 mV (Table 4). K76A had an 
inward current of about -6 µA at -130 mV (Figure 13), and had a <Vmid> of -120  3 mV 
(Table 4). 
A t-test was performed on the <Vmid> values to analyze if each construct’s gating 
potential was significantly independent from that of DM2 at p<0.01 (Table 4). The t-
value of DM2 and PBS-injected was 35.75 and the p-value was < 0.0001, so the DM2 
construct was significantly different from the negative control. The t-value of DM2 and 
CM2 was 0.30 and the p-value was 0.39, so the two constructs were not significantly 
different. The t-value of DM2 and Y72A was -21.75 and the p-value was < 0.00001, so 
the two constructs were significantly different. The t-value of DM2 and K76A was -9.32 
and the p-value was < 0.00001, so the two constructs were significantly different. The t-
value of DM2 and DM2cMyc was 3.19 and the p-value was < 0.01, so the two constructs 
were significantly different. The t-value of DM2 and DM2a was 12.17 and the p-value 
was < 0.00001, so the two constructs were significantly different.  
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3.4 Reversal Potential of DM2 and Mutants 
To assess the ionic species penetrating the DM2 ion channel, the reversal 
potential was measured using two consecutive recordings for each oocyte. The first run 
was for the monitoring of ion channel activity and activation of the ion channels; and the 
second run was for the estimation of the reversal potentials. The reversal potential was 
calculated with the Nernst Equation 
     
  
  
    
      
     
  
where VEq is the voltage potential, R is the universal gas constant, T is the temperature of 
the system in Kelvin, z is the valence of the ion, F is the Faraday constant, [X]out is the 
external concentration of the ion, and [X]in is the internal concentration of the ion. The 
reversal potentials for CM2 and DM2 were -22 mV and -21 mV, respectively (Table 5). 
The valence of the ionic species was calculated as -1 in both cases. When the sodium 
chloride in the ND96 solution (103.6 mM [Cl
-
]) was replaced by 96mM sodium 
methanesulfonic acid (resulted 7.6 mM [Cl
-
]), reversal potentials were reduced to be -7 
mV and -6 mV for CM2 and DM2 respectively. I concluded that DM2 exhibited the 
chloride ion channel activity under the same conditions that the CM2 ion channel activity 
was reproduced, as the reversal potential was lost in the absence of chloride [31]. 
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CHAPTER IV DISCUSSION 
4.1 Chloride-Specificity of  DM2 
The reversal potentials of the ion channels (Table 5) suggest that DM2, Y72A, and K76A 
conduct chloride ions as CM2 does [31], as their reversal potentials in ND96 solution 
(103.6 µM Cl-) do not differ significantly. The mutant reversal potentials in chloride-
substitute ND96 (7.6 µM Cl-), however, are significantly different from CM2 and DM2. 
The results suggest the mutations affect the chloride specificity of the ion channel, but the 
specific mechanism is yet to be determined. Similarly, Influenza A M2 loses proton 
selectivity when His37 is mutated [50]. 
 
4.2 Alteration of C-Terminal domain 
The DM2cMyc-injected oocytes showed negatively greater <Vmid> than that of native 
DM2-injected oocytes. The DM2cMyc protein has an extra 13 amino acids at the C-
terminal of native DM2, including a space and cMyc tag (Figure 4C). I also hypothesized 
that the extended C-terminal end of the polypeptide affects the ion channel function. Thus, 
additional amino acids in the carboxyl end likely contribute to the alteration of the 
channel function. The contribution of the additional amino acids to the gating voltage 
seemed negatively correlated to their hydrophobicity (Figure 4C). The C-terminal domain 
of Influenza A M2 is also necessary for proper ion conductance [24]. 
 
4.3 YxxxK motif 
The gating activity in M2 proteins involves amino acid side chains, namely the cation-pi 
interactions [47]. The cation-pi interactions malfunction when one of the components is 
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missing. In the case of DM2, in the YxxxK motif, Tyr and Lys are potentially charged 
negatively and positively at pH 8.5, respectively. DM2 is likely to have a different valve 
mechanism from AM2 because Tyr and Lys are potentially able to form both ionic 
interactions and cation-pi interactions [48, 49]. With DM2 K76A, the pi provider was 
removed, so the amino acid remained hydrophobic. In the DM2 Lys76Ala, the cation was 
removed and a hydrophobic side chain was introduced. Each step requires a certain 
amount of energy. In both mutated DM2 the gating potential was decreased. The degree 
of decreased potential was greater in Y72A than K76A (Table 4). This fact may indicate 
that Tyr72 provides a greater energy barrier than Lys76. 
 
4.4 Future Direction 
In this study, I have successfully identified ion channel activity in the Influenza DM2 
protein, which is similar to an activity identified in Influenza CM2 (Figure 13) [31]. 
Altered ion channel activity has been identified in the mutant variants altered at the C-
terminal region and the YxxxK motif (Table 4), and the channel has been found to exhibit 
specificity for chloride ions (Table 5). The YxxxK motif is suspected to have a role in the 
gating of chloride ions in the channel, but the mechanism has yet to be identified. 
Specific mechanisms could be determined by solving the 3D structure of the protein, as 
well as through modeling or molecular dynamics. The protein should also be tested for 
susceptibility to antiviral drugs like amantadine and rimantadine, which could contribute 
to the development of drugs to inhibit DM2.  
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Figure 1: Swine as a mixing vessel for Influenza. Influenza virus has species-specificity based on the 
linkages of sialic acid moieties on receptors of hosts. Human Influenza virus recognizes the sialic acid with 
linkage α(2,6), avian Influenza virus recognizes the sialic acids with linkage α(2,3), and swine Influenza 
virus recognizes both [11]. As swine cells have each sialic acid linkage recognized by avian and human 
Influenza viruses, human and avian Influenza viruses have the capacity to infect a swine host [9]. This 
creates an environment in swine where the different Influenza virus species can infect the same cells and 
potentially engage in genetic reassortment, causing new Influenza types to emerge. 
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Figure 2: Roles of M2 protein in Influenza A replication. The Influenza virus hemagglutinin (HA) 
recognizes sialic acid moieties of receptors on the host plasma membrane (1). This triggers receptor-
mediated endocytosis of the virus (2). Viral hemagglutinin binds to the endosomal membrane, and the 
acidic environment of the endosome (pH 5-6) activates the matrix protein 2 (M2) ion channel, leading to 
rupture of the virus particle and the endosomal membrane (3). The viral ribonucleoproteins are transported 
to the cell nucleus (4), and viral mRNA is synthesized (5). The viral mRNAs encoded genes are then 
translated into proteins (6). Viral proteins are transported to the cell membrane with newly synthesized 
viral ribonucleoproteins (7). New Influenza viruses are budded out of the cell (8). M2 is a critical part of at 
least two of these stages. The first is the release of vRNPs into the host cell cytoplasm (3). M2 is 
responsible for channeling ions and acidifying the virus interior, causing the fused endosome to rupture. 
The second stage is the budding of new viruses from the host cell (7 and 8). M2, along with HA and 
neuramidase (NA), is required in order for a virus particle to bud properly [13]. 
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Figure 3: Chemical structure of amantadine. Amantadine (PubChem CID, 2130) is an antiviral drug that 
inhibits Influenza virus reproduction by blocking the M2 ion channel [16,17]. Amantadine is no longer 
recommended as an antiviral treatment in the first choice, as the drug is only semi-effective against recent 
virus types. The drug has been tested against Influenza C, with no evidence for the inhibition of M2 [31]. 
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                      [Y] 
CM2   -24 MGRMAMKWLVVIICFSITSQPASA -1 
DM2     1 MANLALKRSVLTLLMLVI------ 18 
 
          *    *[N]             g       *                               
CM2     1 CNLKTCLK-----------LFNNTDAVTVHCFNENQGYMLTLASLGLGIITMLYLLVKIIIEL----VNGFVLG 59 
DM2    19 CGIPTCVNAETVEEFCRKKLNQTEEKVYVHCFNEDDGRAMTLAALILGCFSMLYILIKAILMLLLTIINGRPNG 92 
 
              p                   [F] 
CM2    60 RWERWCGDIKTTIMPEIDSMEKDIALSRERLDLGE-DAPDETDNSPIP-FSNDGIF--EI                 
115 
DM2    93 NWDDLKHVVKCFSETGSENFARDIMVLESRRDGEETSSPEEGLGPPLSGFNENGVFMETL                 
152 
DM2m   93 NWDDLKHVVKCFSETGSENFARDIMVLESRRDGEETSSPEEGLGPPLSGFNENGVFMETLGAGEQKLISEEDL    
165 
DM2a   93 NWDDLKHVVKCFSETGSENFARDIMVLESRRDGEETSSPEEGLGPPLSGFNENGVFSRAADLVTTKPASRTPEWSL 
168 
 
A 
                            
AM2   19 SNASSDPLVVAASIIGILHLILWILDRLFFKSIYRFFEHGLKRG 62 
BM2    1 MLEPFQILSICSFILSALHFIAWTIGHLNQIKRGINMKIRIKGP 44 
CM2   25 QGYMLTLASLGLGIITMLYLLVKIIIELVNGFVLGRWERWCGDI 68 
DM2   54 DGRAMTLAALILGCFSMLYILIKAILMLLLTIINGRPNGSWDDL 97                           
 
B 
                                                                                            
GRAVY 
DM2  130 VFMETL                    1.417 
         EEEE-- 
DM2m 130 VFMETLGAGEQKLISEEDL      -0.032 
         EEEEE------HH------ 
DM2a 130 VFSRAADLVTTKPASRTPEWSL   -0.195 
         ---------E------------ 
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Figure 4. Amino acid sequences. A. Primary structures of Influenza C virus M2 protein (CM2; 
Sequence ID, YP_089658.1 (C/Ann Arbor/1/1950)) and Influenza D virus M2 protein (DM2; AFJ19025 
(D/Swine/Oklahoma/1334/2011)). CM2 contains a 24 amino-acid-signal sequence (−24 to −1). Mature 
CM2 starts with Cys1, and contains from the amino terminal reported extracellular, transmembrane 
(underlined), and internal domains. Amino acid substitutions between Yamagata (BAA03793.1 
(C/Yamagata/1/1988)) and Ann Arbor isolates were indicated in brackets. CM2 has disulfide-linked 
oligomerization sites (‘*’; Cys1, Cys6, Cys20), a glycosylation site (Asn11, ‘g’) and a palmitoylation site 
(Cys65, ‘p’). In DM2, the predicted transmembrane domain was indicated by underline. The YxxxK motif, 
Tyr72 and Lys76 in D, was indicated by the bold face. A C-terminal variant in Dm has a spacer GAG and a 
cMyc-tag EQKLISEEDL. A  C-terminal variant in DM2, DM2a, has an extra peptide from the vector, 
pNCB1. B. Structures of M2 proteins. AM2. M2 protein from Influenza A virus (AAA43303 
(A/Udorn/1972(H3N2)) has a NMR structure (residues 22–62; PDB ID, 2L0J) and crystallographic 
structure (21–46; 4QKL). BM2. M2 protein from Influenza B virus (ACF54325.1 (B/Taiwan/70061/2006)) 
has a NMR structure (1–33; 2KIX). CM2. M2 protein from Influenza C virus has structures by site-specific 
infrared dichroism (27–46; [18]). DM2. M2 protein from Influenza D virus is in this study. Solved or 
predicted structures were underlined. Amino acid residues providing experimental structure information are 
indicated by underlines. C. Predicted secondary structure and the hydrophobicity value, GRAVY, of 
carboxyl ends in DM2 constructs. Predicted secondary structures E and H correspond to -strand and -
helix, respectively. In GRAVY, greater positive values indicate higher hydrophobicity. 
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Figure 5. 3D-structure of M2 protein. A. The structure of AM2 was solved experimentally by nuclear 
magnetic resonance spectroscopy (NMR; structures were deposited in Protein Data Bank with the ID cede 
2L0J; the NMR structure contains multiple structures and shown is model 1 out of 8 is shown). The AM2 
adopts a homo-tetramer configuration, and the middle of the assembly contains a pre. The valve residues, 
His37 and Trp41, face inward within the pore on each monomer. B. The monomer structure of AM2 with 
valve resides, which control ion flow by pseudo-cation-pi interaction. C. A theoretical model of DM2 in 
monomer format. 
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Figure 6: pNCB1 plasmid vector. 1. Plasmid construction. DM2, DM2cMyc, and CM2 were each cloned 
into the pNCB1 vector with the BamHI and XbaI sites. DM2a was cloned into pNCB1 using SmaI and XbaI. 
The DM2, DM2cMyc, DM2a, and CM2 genes encode 152, 165, 168, and 139 amino acids, respectively, 
and their structural genes are 459, 495, 504, and 417 bp, respectively. The HindIII linearization locations 
and lengths for synthesized cRNA for each respective plasmid construct are also shown. 2. The sequence of 
the T7 promoter. The +1 of cRNA synthesis was shown. 3. Restriction sites. The multiple cloning sites 
locates between the 5’UTR and 3’UTR regions. The cut sites are noted by the underline. 4. The physical 
map of the pNCB1. The vector had several cut sites available for linearization. HindIII 738 and Pci1 1097 
were utilized in this research. 
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Table 1: The amount of synthesized cRNA.  
Synthesized cRNA Quantification Volume Total amount 
CM2 140 ng/µL 10 µL 1400 ng 
DM2 292 ng/µL 10 µL 2920 ng 
DM2a 128 ng/µL 10 µL 1280 ng 
DM2cMyc 232 ng/µL 10 µL 2320 ng 
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Figure 7: Agarose gel electrophoresis of linearized DNA and cRNA. A. Linearized plasmid vectors by 
HindIII. Recovered DNAs were analyzed by 1% agarose gel electrophoresis. For each lane, 3 µL sample 
was loaded.  Lanes were: 1, the 1 kb GeneRuler ladder; 2, CM2; 3,  DM2; 4, DM2a; and 5, DM2cMyc. The 
length of plasmid vectors were ranged between 3411 bp and 3469 bp. B. Synthesized cRNA. cRNA was 
analyzed by the same electrophoresis conditions. Lanes were: 1, 1 kb GeneRuler ladder; 2, CM2; 3, DM2; 
4, DM2a; 5, DM2cMyc.  
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Figure 8: Fluorometer sample quantification. The intensity of fluorescence was calibrated using vendor 
provided a 0 ng/µL standard and a 500 ng/µL standard (indicated by diamonds). The intensity of 
fluorescence for each sample was measured (solid squares).  
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Figure 9: Nanoinjection of Xenopus oocyte. cRNA suspended in 1 M PBS solution (1) was brought into a 
glass pipette (2) secured on the nanoinjector. The nanoinjector was used to penetrate the glass pipette into 
healthy Xenopus oocytes resting in  D 6 pH  .5 solution kept at about 4  C (3), and then used to in ect the 
cR A (50.6 n ) into the oocyte (4). The in ected oocyte was then incubated at 1   C for 48-72 hours (5) to 
allow the injected cRNA to be translated and expressed in the oocyte.  
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Table 2: Connections for OC-725C and Digidata devices.  
OC-725C Digidata 
GAIN TELEGRAPH OUTPUT GAIN TELEGRAPH INPUT #3 
I MONITOR ANALOG IN #0 
VM x 10 ANALOG IN #1 
COMMAND IN ÷10 ANALOG OUT #0 
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Table 3: pCLAMP configurations. 
Navigation Configuration/Selection 
1. Configure/Telegraphed Instrument  
1a. INPUT CHANNELS Analog input #0 
1b. TELEGRAPH INSTRUMENT OC-725C 
1c. TELEGRAPH CONNECTIONS Telegraph input 3 
2. Configure/Lab Bench  
2a. Input Signals  
2a.i. DIGITIZER CHANNELS/Analog IN #0  
2a.i.1. SIGNALS Add ‘Current’ 
2a.i.2. SCALING Signal units µA 
 Scale factor 1 V/µA 
2a.ii. DIGITIZER CHANNELS/Analog IN #1  
2a.ii.1. SIGNALS Add ‘Voltage’ 
2a.ii.2. SCALING Signal units mV 
 Scale factor 0.01 V/mV 
2b. Output Signals  
2b.i. DIGITIZER CHANNELS/Analog IN #0  
2b.i.1. SIGNALS Add ‘Holding’ 
2b.i.2. SCALING Signal units mV 
 Scale factor 100 mV/V 
3. Acquire/Edit Protocol  
3a. Mode/Rate Acquisition Mode set to ‘ pisodic’ 
3b. Inputs Channel #0, select ‘Current’ 
 Channel #1, select ‘Voltage’ 
3c. Outputs Channel #0, select ‘Holding’ 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
29 
 
Figure 10: Two-electrode voltage clamp setup. 1. An oocyte in ND96 solution with its membrane 
impaled by the voltage and current electrodes of the voltage clamp. Only slight dimpling should occur in 
the oocyte membrane after impalement. 2. Each component of the voltage clamp is listed in the figure. The 
voltage clamp was connected to the computer with pCLAMP installed via an amplifier, and the pCLAMP 
software was used to automatically command the holding potential of the oocyte and record the changes in 
current. The Vm (voltage of the membrane) electrode was secured by the Vm headstage, and held the 
oocyte’s membrane at a constant (holding) voltage. The current electrode was secured by the current 
electrode holder, and was responsible for compensating for the current generated by the oocyte to maintain 
the holding potential and to deliver data to pCLAMP. The bath clamp headset maintained a virtual ground 
with Isense and Iout electrodes placed in the oocyte bath. The aluminum shield acted as a Faraday cage to 
block external electrostatic noise (if necessary) and was connected to the bath clamp. 
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Figure 11. Mass spectrometry and the peptide identification. Trypsin was added to a ND96 medium 
containing an oocyte injected by RNA encoding c-Myc tagged DM2. Mass spectrometry identified the C-
terminal region, RDGEETSSPEEGLGPPLSGFNENGVFMETLGAGEQK, which contains a partial cMyc 
sequence (Figure 1). 
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Figure 12. Confocal microscopic photography of oocytes. A. An oocyte injected by phosphate buffer 
saline. B. An oocyte injected by RNA encoding c-Myc tagged DM2. Oocyte were treated by anti-cMyc 
antibody (mouse 9E10) and then by donkey anti-mouse Alexa-Fluor 488 antibodies. 
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Figure 13. Induced current recorded by Two-electrode voltage-clamp at pH 8.5. A. Induced current 
(I) and given membrane potential (Vm) over time. An oocyte injected by either RNA or phosphate 
buffer saline was subjected to the TEVC recording, and the current measurement during the holding 
potential was given for 2 s. A relax time, 5 s, was given before the next measurement. B. Plots for induced 
current and the membrane potential; typical single measurements. 
<Vmid>: Mean simulated membrane potential which gives a half of ion channel opens (Vmid) by the charge-
voltage Boltzmann distribution model. Correlation Coefficients in the Boltzmann curve fit was at least 0.85. 
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Table 4. The charge-voltage Boltzmann distribution model in Two-electrode voltage 
clamp (N=5). A t-test was performed on each <Vmid> to test if it was significantly 
different from the <Vmid> of DM2 at *p < 0.01. 
Sample <Vmid> / mV N. 
CM2  -141  10 5 
DM2  -139  3 5 
DM2 Y72A  -103  2* 5 
DM2 K76A -120  3* 5 
DM2cMyc  -155  11* 5 
DM2a  -168  4* 5 
PBS  -203  2* 5 
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Table 5. Reversal potential (RP; N=5). 
M2 RP in ND96 (mV) RP in ND96 replaced Cl (mV) 
DM2 -20.95  1.05  -5.84  0.40 
DM2 Y72A -21.77  0.77 -9.75  1.97 
DM2 K76A -21.19  1.34 -14.03  2.34 
CM2 -22.05  1.19 -6.52  2.06 
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DM2_native   1 ggatccatggctaacctggctttgaagaggagcgtcctgaccttgcttatgcttgtgatt  60 
DM2_K76A     1 ggatccatggctaacctggctttgaagaggagcgtcctgaccttgcttatgcttgtgatt  60 
DM2_Y72A     1 ggatccatggctaacctggctttgaagaggagcgtcctgaccttgcttatgcttgtgatt  60 
DM2a         1 ggatccatggctaatcttgccctaaaaaggtcagttcttactttgttaatgttggtaatt  60 
DM2_cMyc     1 ggatccatggctaatcttgccctaaaaaggtcagttcttactttgttaatgttggtaatt  60 
 
DM2_native  61 tgcggaatacccacctgcgtgaatgctgagaccgttgaagagttttgtagaaaaaagctg 120 
DM2_K76A    61 tgcggaatacccacctgcgtgaatgctgagaccgttgaagagttttgtagaaaaaagctg 120 
DM2_Y72A    61 tgcggaatacccacctgcgtgaatgctgagaccgttgaagagttttgtagaaaaaagctg 120 
DM2a        61 tgtgggatccccacttgtgtaaatgctgaaactgtggaagaattttgtagaaagaaacta 120 
DM2_cMyc    61 tgtggcatccccacttgtgtaaatgctgaaactgtggaagaattttgtagaaagaaacta 120 
 
DM2_native 121 aatcagacagaagagaaagtctatgtgcattgcttcaacgaagatgacggaagggccatg 180 
DM2_K76A   121 aatcagacagaagagaaagtctatgtgcattgcttcaacgaagatgacggaagggccatg 180 
DM2_Y72A   121 aatcagacagaagagaaagtctatgtgcattgcttcaacgaagatgacggaagggccatg 180 
DM2a       121 aatcagacggaagaaaaggtttatgtccattgtttcaatgaggatgatggtcgggcaatg 180 
DM2_cMyc   121 aatcagacggaagaaaaggtttatgtccattgtttcaatgaggatgatggtcgggcaatg 180 
 
DM2_native 181 actctggctgcactgatccttggctgtttttccatgttgtacatactgattaaggctata 240 
DM2_K76A   181 actctggctgcactgatccttggctgtttttccatgttgtacatactgattgcggctata 240 
DM2_Y72A   181 actctggctgcactgatccttggctgtttttccatgttggcgatactgattaaggctata 240 
DM2a       181 actttagctgctttgatacttggatgctttagtatgctttacattttaataaaggcaata 240 
DM2_cMyc   181 actttagctgctttgatacttggatgctttagtatgctttacattttaataaaggcaata 240 
 
DM2_native 241 ctgatgctgcttttgacaattatcaatgggagacccaatggtaactgggatgaccttaaa 300 
DM2_K76A   241 ctgatgctgcttttgacaattatcaatgggagacccaatggtaactgggatgaccttaaa 300 
DM2_Y72A   241 ctgatgctgcttttgacaattatcaatgggagacccaatggtaactgggatgaccttaaa 300 
DM2a       241 ctgatgcttttgttgacaatcataaatggaagaccaaatggaaattgggatgacttgaaa 300 
DM2_cMyc   241 ctgatgcttttgttgacaatcataaatggaagaccaaatggaaattgggatgacttgaaa 300 
 
DM2_native 301 cacgtggttaagtgcttttccgaaaccggaagtgagaacttcgctagggatattatggtg 360 
DM2_K76A   301 cacgtggttaagtgcttttccgaaaccggaagtgagaacttcgctagggatattatggtg 360 
DM2_Y72A   301 cacgtggttaagtgcttttccgaaaccggaagtgagaacttcgctagggatattatggtg 360 
DM2a       301 cacgttgtaaaatgtttttcagagactggaagtgagaacttcgccagggatataatggtc 360 
DM2_cMyc   301 catgttgtaaaatgtttttcagagactggaagtgagaacttcgccagggatataatggtc 360 
 
DM2_native 361 ctggaatcaagaagggacggggaagagacatctagccctgaagagggacttggcccacct 420 
DM2_K76A   361 ctggaatcaagaagggacggggaagagacatctagccctgaagagggacttggcccacct 420 
DM2_Y72A   361 ctggaatcaagaagggacggggaagagacatctagccctgaagagggacttggcccacct 420 
DM2a       361 ctggaatccaggcgagatggggaggagacaagctccccagaggagggactaggccctcca 420 
DM2_cMyc   361 ctggaatccaggcgagatggggaggagacaagctccccagaggagggactaggccctcca 420 
 
DM2_native 421 ttgtctggcttcaatgagaacggtgtttttatggagaccct------------------- 461 
DM2_K76A   421 ttgtctggcttcaatgagaacggtgtttttatggagaccct------------------- 461 
DM2_Y72A   421 ttgtctggcttcaatgagaacggtgtttttatggagaccct------------------- 461 
DM2a       421 ttgagtggattcaatgaaaatggtgtattc------------------------------ 450 
DM2_cMyc   421 ttgagtggattcaatgaaaatggtgtattcatggaaacattaggcgcgggcgaacaaaaa 480                           
 
DM2_native 462 --------------------ttaatctaga 471 
DM2_K76A   462 --------------------ttaatctaga 471 
DM2_Y72A   462 --------------------ttaatctaga 471 
DM2a       451 ------------------------tctaga 456 
DM2_cMyc   481 ctcatctcagaagaggatctgtaatctaga 510 
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DM2_native   1 MANLALKRSVLTLLMLVICGIPTCVNAETVEEFCRKKLNQTEEKVYVHCFNEDDGRAMTL  60 
DM2_Y72A     1 MANLALKRSVLTLLMLVICGIPTCVNAETVEEFCRKKLNQTEEKVYVHCFNEDDGRAMTL  60 
DM2_K76A     1 MANLALKRSVLTLLMLVICGIPTCVNAETVEEFCRKKLNQTEEKVYVHCFNEDDGRAMTL  60 
DM2a         1 MANLALKRSVLTLLMLVICGIPTCVNAETVEEFCRKKLNQTEEKVYVHCFNEDDGRAMTL  60 
DM2_cMyc     1 MANLALKRSVLTLLMLVICGIPTCVNAETVEEFCRKKLNQTEEKVYVHCFNEDDGRAMTL  60 
 
DM2_native  61 AALILGCFSMLYILIKAILMLLLTIINGRPNGNWDDLKHVVKCFSETGSENFARDIMVLE 120 
DM2_Y72A    61 AALILGCFSMLAILIKAILMLLLTIINGRPNGNWDDLKHVVKCFSETGSENFARDIMVLE 120 
DM2_K76A    61 AALILGCFSMLYILIAAILMLLLTIINGRPNGNWDDLKHVVKCFSETGSENFARDIMVLE 120 
DM2a        61 AALILGCFSMLYILIKAILMLLLTIINGRPNGNWDDLKHVVKCFSETGSENFARDIMVLE 120 
DM2_cMyc    61 AALILGCFSMLYILIKAILMLLLTIINGRPNGNWDDLKHVVKCFSETGSENFARDIMVLE 120 
 
DM2_native 121 SRRDGEETSSPEEGLGPPLSGFNENGVFMETL---------------- 152 
DM2_Y72A   121 SRRDGEETSSPEEGLGPPLSGFNENGVFMETL---------------- 152 
DM2_K76A   121 SRRDGEETSSPEEGLGPPLSGFNENGVFMETL---------------- 152 
DM2a       121 SRRDGEETSSPEEGLGPPLSGFNENGVFSRAADLVTTKPASRTPEWSL 168 
DM2_cMyc   121 SRRDGEETSSPEEGLGPPLSGFNENGVFMETLGAGEQKLIS---EEDL 165 
 
Figure 14. MAFFT alignment of DM2 native, DM2 Y72A, DM2 K76A, DM2a, and DM2cMyc DNA 
and amino acid sequences. The yellow highlighted codons correspond to Tyr72 of DM2. The blue 
highlighted codons correspond to Lys76 of DM2. The gray highlighted codons correspond to the Ala 
substitutions in Tyr72Ala and Lys76Ala. Each nucleotide sequence begins with its BamHI cloning site 
(GGATCC) and ends with its XbaI cloning site (TCTAGA). 
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